WO1981000670A1 - Pre-coated body implant - Google Patents

Pre-coated body implant Download PDF

Info

Publication number
WO1981000670A1
WO1981000670A1 PCT/US1980/001141 US8001141W WO8100670A1 WO 1981000670 A1 WO1981000670 A1 WO 1981000670A1 US 8001141 W US8001141 W US 8001141W WO 8100670 A1 WO8100670 A1 WO 8100670A1
Authority
WO
WIPO (PCT)
Prior art keywords
cement
implant
prosthesis
coating
stem
Prior art date
Application number
PCT/US1980/001141
Other languages
French (fr)
Inventor
G Pratt
J Chung
R Poss
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Priority to DE19803049857 priority Critical patent/DE3049857A1/en
Publication of WO1981000670A1 publication Critical patent/WO1981000670A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30014Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3625Necks
    • A61F2002/3631Necks with an integral complete or partial peripheral collar or bearing shoulder at its base
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • A61F2002/3678Geometrical features
    • A61F2002/3686Geometrical features bent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00952Coating, pre-coating or prosthesis-covering structure made of bone cement, e.g. pre-applied PMMA cement mantle

Definitions

  • Bone-cement made of polymethyl methacrylate is intro ⁇ quizzed into the medullary canal between the prosthesis stem and the inner aspect of the femur. This layer of bone-cement enables distribution of impressed load over a larger area than would otherwise be the case.
  • the bone structure when stressed must deform. If no overstressing or local stress concentrations are to occur, the bone must be allowed to deform in its natural way. Therefore, the only manner for accommodating this is by utilizing an intermediate layer of an elastic substance whose Young's modulus is lower than that of the implant and that of the bone. Polymethyl methacry ⁇ late satisfies such requirements.
  • the inside of the upper half of the femoral shaft is generally covered with a more or less marked spongiosa layer, which is formed by sheets of spongiosa running circularly.
  • the anchorage is as good as in the spongiosa of the trochanter. Only where the cor ⁇ tex is exposed in the femur is keying no longer possible in the manner described.
  • the cement does 'not hold onto smooth surfaces and, owing to the volumetric shrinkage during cooling, the cement filling contracts somewhat, so that it fits loosely inside a smooth bone tube.
  • the acrylic bone- cement does not adhere very firmly either to the usual socket plastics or to metals. Accordingly, firm fixa- tion of the prosthesis in the cement can be achieved only by mechanical keying.
  • Prosthesis metals have a coefficient of cubical expansion about three times lower than that of the acrylic cement. Consequently, during thermal contraction in the course of cement in- situ polymerization, the prosthesis stem surrounded by cement shrinks less than the cement, so that the latter tightens its grip.
  • the cement to implant here the hip prosthesis
  • This bond is much more subject to faulty implantation in the actual operating room situation than the bond that can be achieved between old hardened cement and new cement that cures on the surface of an already cured cement layer.
  • Faulty implantation is often a surgical error caused by varus positionings of prosthesis, improper curing of cement, insufficient amount of cement used, or movements incurred during surgery.
  • Varus positioning of prosthesis has been described earlier. Lack of monomer of the acrylic cement during curing process due to, for example, excessive amounts of the monomer being dissolved in the surrounding adipose tissue during poly ⁇ merization can occur. The strength of the cement thus formed will be greatly degraded and would not be able to sustain much shear stress at the interface. An insuf- ficient amount of cement will produce voids, inside the medullary canal and give rise to local stress con ⁇ centration, which in turn will cause eventual loosening.
  • Polymers such as poly methyl methacrylate, are usually described as viscoelastic materials, a generic term which emphasizes their intermediate posi ⁇ tion between viscous liquid and elastic solids.
  • a polymer may be glass-like with a Young's modulus of 10---0 - 10-*--*- dyne/cm-2, whereas at high tempera ⁇ tures, the same polymer may be rubber-like with a Young's modulus of 10 7 - 10 8 dyne/cm 2 .
  • permanent deformation occurs under load, and the polymer behaves like a viscous liquid.
  • the polymer In an intermediate temperature, 'commonly called the glass transition range, the polymer is neither glassy nor rubbery. It shows an intermediate modulus, is viscoelastic and may dissipate a con- siderable amount of energy on being strained.
  • the glass transition manifests itself in several ways, for example by a change in the volume coefficient of expansion, which can be used to define a glass-transition tem ⁇ perature Tg.
  • Pre-coated components ensure maximum mechani ⁇ cal coupling at the implant/cement interface which can be prepared controllably and reproducibly pre- operatively, thus shifting the emphasis at the time of surgery to the cement/cement and cement/bone interfaces. Since the quality of chemical bonding is less suscep- table to external disturbance than mechanical bonding during in-situ cement polymerization the incidence of loosening due to movements during surgery would drasti- cally be reduced. Furthermore, appropriate engineering and processing procedures can be employed to produce a layer of pre-bonded cement with the desired mechanical properties and devoid of bubbles and other defects pre- operatively on the surface of the femoral component. Another factor that can be controlled in a pre-coating implant is the modulus of elasticity of the cement pre- coating.
  • the metal implant will have a Young's modulus typically 10 times higher than the cement that grips the implant. Thus at the implant-cement interface there is a discontinuity in stiffness. The greater this discon- tinuity, the greater will be the displacement of one surface relative to the other at the interface when the composite system is subjected to a mechanical load.
  • a pre-coated body implant that includes, in com ⁇ bination, a structural member having a portion that is adapted to bond mechanically to a skeletal member of the body; and a cement pre-coating covering at least a substantial part of said portion of the structural member, which cement pre-coating clings to said portion.
  • a similar cement may be used in the bond cavity.
  • Fig. 1 is a isometric view of a pre-coated body implant
  • Fig. 2 is a section view, slightly enlarged, taken upon the line 2 - 2 in Fig. 1 and looking in the direction of the arrows;
  • Fig. 3 is a view like that in Fig. 2 but of a modification of the implant of Fig. 2.
  • Fig. 4 is a graph showing the Young's modulus of methyl ethacrylate, (a material that may be used as the pre-coating on the implant in Fig. 1) as a function of absolute temperature, and
  • Fig. 5 is a graph showing specific volume as a function of absolute temperature for that same material.
  • the implant labeled 101 therein will be recognized as a prosthesis used in hip implant applications.
  • a prosthesis of the type shown most generally is formed of metals such as stainless steel, cobalt-chromium, alloys e.g., (Vitallium) with only slight irregularities to aid cement fixation.
  • the implant 101 has a stem 1, a shoulder 3, and a ball 4.
  • the stem 1 when implanted in a body, is received by a cavity formed by a physician in the femur of a patient.
  • the cavity is reamed to a size sufficient to receive the stem 1 and a volume of a doughy cement (e.g., methyl methacrylate, referred to as "MMA").
  • MMA methyl methacrylate
  • the bone cavity should be free of blood and be dry so that no blood or other fluid interferes with grouting achieved by the cement to the bone or prosthe ⁇ sis.
  • the inserted prosthesis is held in place by the operating physician until polymerization of the MMA is complete; no motion of the prosthesis should take place during the period of approximately ten to fifteen minutes it takes for polymerization to occur. (See said application for Letters Patent S.N. 026,462, Babyn et al, filed April 2, 1979 for a further discussion.)
  • the implant 101 In the usual installation, the implant 101, originally has a stem 1 which is shiny metal (usually Vitallium) and which fills that portion of the bone cavity not taken up by a cement.
  • the implant 101 when installed in a femur is held there mostly by frictional interaction between the MMA and the femur at one bonding region and between the MMA and the implant at the other bonding region.
  • the ideas herein are intended to strengthen the cement-to-implant bond which is a region that can loosen and fail, as previously noted herein.
  • a pre-coating 2 in Figs. 1 and 2 of MMA or some other acrylic or other material is applied to the stem 1 of the prosthesis.
  • the bond between the stem 1 and the pre-coating 2 is a mechanical bond which is achieved to a great degree by shrinkage of the pre-coating 2 upon curing; hence the pre-coating 2 must be thick enough to provide adequate tensile strength to assure that mechanical bond.
  • a pre-coating in a metal prosthesis of optimum thickness ensures that there will be no prosthesis-bone contact in the event of improper prosthesis positioning, that is, the prosthesis will enjoy at least some cement covering and of optimal thickness.
  • a pre-coating can be provided with irregu- larities (see the ridges on other irregularities marked 5 in the pre-coating labeled 2A in Fig. 3), thus increasing the contact area of cement/cement in the implant to provide a better mechanical and/or chemical bond. Irregularities cannot be provided in the metal stem 1 because they would result in concentrated stress which could lead to failure of that stem.
  • the thickness of the pre-coating of layer 2 can be optimized, thereby reducing the amount of polymerized (doughy) cement introduced into the bone during implantation and, there- fore, the circulation would be less. It is felt on the basis of other reports that decreased exposure to monomer is desirable. Also, by increasing the mass of the prosthesis with a polymerized cement layer, better compaction of the doughy cement into the intesticies of cancellous bone can be achieved; i.e., a larger stem acts as a plunger forcing doughy cement under high pressure into cancellous bone.
  • pre-polymerization in a quality controlled setting a better bond can be achieved; e.g., a varying of the temperature of poly- merization and cooling can be employed to effect better bonding of cement-to-metal if greater contraction of cement can be achieved (see Figs. 4 and 5).
  • the pre- coating can be applied in such a way that the elastic modulus of the coating takes on a value or range of values intermediate between the implant and the cement inserted during actual surgery. This gradation in ' stiffness will decrease the relative motion due to mechanical loading. Also, such problems as blood clots or fluid forming on the interface between cement and prosthesis is obviated.

Abstract

A pre-coated body implant (101), such as, for example, a hip prosthesis, in which that portion (1) of the implant that attaches to or is inserted into a skeletal member of the body has a pre-coating (2) of a material (e.g., an acrylic material) covering all or most of said portion and bonded there to. Incidence of loosening of the implanted prosthesis may be reduced due to the fact that a controlled me chanical bonding may be accomplished prior to surgery, shifting emphasis to the cement/cement and cement/bone interfaces during surgery. Since these are chemical bonds, there is less chance of loosening due to movements during surgery.

Description

PRE-COATEDBODYIMPLANT
A very severe problem with regard to bone implants is the tendency of such implant to become loose or, indeed, to be loose even at the time of implanta¬ tion. Currently in the United States approximately ten percent of the population reportedly has discernible symptoms of arthritic disease. Despite the lesser mortality rate than that of heart disease and cancer, this form of disability creates tremendous psychologi¬ cal, physical and economic impact on the patients because of pain and functional impairments incurred. The consequent loss of manpower and increase in health care expenses are substantial. Thus, rehabilitation of damaged joints is of great concern to the social and economic well-being of the community. Recent advances in the field of total-hip arthroplasty have given much optimism to the improvement of clinical management in this area, and brought promise of relief from hip pain, improved gait, and a satisfactory range of motion.
Successful replacement surgery depends heavily on the clinical expertise of an experienced and artistic surgeon as well as on the proper designs of clinical prosthesis, many of which now in use, unfortunately, are still classified as experimental devices, some one hundred types in all. Until accurate information on the biomechanical behavior of the system is known, complica¬ tions of such surgery will inevitably arise such as loosening of the femoral prosthesis. Loosening is the most prevalent long-term complication of total-hip arthroplasty. An imbalance of the distribution of for¬ ces carried by surrounding soft tissues caused by patho¬ logical alteration will strain the joint to develop deformation which, in turn, leads to eventual loosening. There are other factors that could induce loosening, which will be discussed in more detail. When loosening occurs in the absence of infection, the femur is almost always affected. Once firm fixation is lost, loosening is usually progressive. Breakage of bone and/or pros- thesis will result, which could lead to life-long dis¬ ability. It has been shown that even the slightest amount of loosening can be of critical importance in producing high stress levels in the prosthesis stem and that rigid fixation of the entire stem is essential. It has also been observed that movement during surgery can easily occur, thereby enhancing the possibility of even¬ tual loosening. The introduction of acrylic cement to achieve rigid fixation of metal and plastic prosthesis to bone twenty years ago revolutionized arthroplasty. Bone-cement made of polymethyl methacrylate is intro¬ duced into the medullary canal between the prosthesis stem and the inner aspect of the femur. This layer of bone-cement enables distribution of impressed load over a larger area than would otherwise be the case. The bone structure when stressed must deform. If no overstressing or local stress concentrations are to occur, the bone must be allowed to deform in its natural way. Therefore, the only manner for accommodating this is by utilizing an intermediate layer of an elastic substance whose Young's modulus is lower than that of the implant and that of the bone. Polymethyl methacry¬ late satisfies such requirements.
Success of implant fixation depends largely on mechanisms of the interfaces. Therefore, it is appropriate to study the mechanical structure at the interfaces.
Between cement and bone tissue there is no real adhesion. The mechanical strength of the bond be¬ tween the two materials derives its strength from the action of interdigitation. To prepare the cement bed in bone., part of the spongiosa is removed. This leaves an irregular surface, characterized by projecting, broken- off spongiosa ridges with marrow still located at the bottom of the recesses. By forcing the prosthesis stem mechanically, the cement is forced into these recesses and surround the spongiosa trabeculae. Owing to the shrinkage of the cement in curing and cooling (about 4% in volume) , the more or less hardened cement may withdraw somewhat from the surrounding spongiosa.
The inside of the upper half of the femoral shaft is generally covered with a more or less marked spongiosa layer, which is formed by sheets of spongiosa running circularly. Here the anchorage is as good as in the spongiosa of the trochanter. Only where the cor¬ tex is exposed in the femur is keying no longer possible in the manner described. The cement does 'not hold onto smooth surfaces and, owing to the volumetric shrinkage during cooling, the cement filling contracts somewhat, so that it fits loosely inside a smooth bone tube.
Turning now to the prosthesis/cement interface which is crucial in this disclosure, the acrylic bone- cement does not adhere very firmly either to the usual socket plastics or to metals. Accordingly, firm fixa- tion of the prosthesis in the cement can be achieved only by mechanical keying. Prosthesis metals have a coefficient of cubical expansion about three times lower than that of the acrylic cement. Consequently, during thermal contraction in the course of cement in- situ polymerization, the prosthesis stem surrounded by cement shrinks less than the cement, so that the latter tightens its grip. It should be clearly understood that the cement to implant (here the hip prosthesis) bond is one of mechanical gripping not a chemical adhesion. This bond is much more subject to faulty implantation in the actual operating room situation than the bond that can be achieved between old hardened cement and new cement that cures on the surface of an already cured cement layer. In considering the pathogenesis of loosening of prosthetic components it may be helpful to examine closely factors that are conducive to the loosening of prosthetic components.
Faulty implantation is often a surgical error caused by varus positionings of prosthesis, improper curing of cement, insufficient amount of cement used, or movements incurred during surgery. Varus positioning of prosthesis has been described earlier. Lack of monomer of the acrylic cement during curing process due to, for example, excessive amounts of the monomer being dissolved in the surrounding adipose tissue during poly¬ merization can occur. The strength of the cement thus formed will be greatly degraded and would not be able to sustain much shear stress at the interface. An insuf- ficient amount of cement will produce voids, inside the medullary canal and give rise to local stress con¬ centration, which in turn will cause eventual loosening.
In most general terms, polymers change from rubber-like to glass-like behavior as the temperature is lowered. In the glassy state at low temperatures one would expect the stiffness to relate to the stored elastic energy on deformation which are associated with small displacements of the molecules from their equilibrium positions. In the rubbery state, on the other hand, at high temperatures, the molecular chains have considerable flexibility; so in the deformed state they can adopt conformations which lead to maximum entropy or, more strictly, minimum free energy. The rubberlike elastic deformations are then related to
-E changes in molecular conformations. The ease with which the polymer can jump from one conformation to another is often described by the so-called jump frequency. Accordingly, the rate of polymerization will increase with the ambient temperature at the time of mixing.
Polymers, such as poly methyl methacrylate, are usually described as viscoelastic materials, a generic term which emphasizes their intermediate posi¬ tion between viscous liquid and elastic solids. At low temperatures, a polymer may be glass-like with a Young's modulus of 10---0 - 10-*--*- dyne/cm-2, whereas at high tempera¬ tures, the same polymer may be rubber-like with a Young's modulus of 107 - 108 dyne/cm2. At still higher temperatures, permanent deformation occurs under load, and the polymer behaves like a viscous liquid.
In an intermediate temperature, 'commonly called the glass transition range, the polymer is neither glassy nor rubbery. It shows an intermediate modulus, is viscoelastic and may dissipate a con- siderable amount of energy on being strained. The glass transition manifests itself in several ways, for example by a change in the volume coefficient of expansion, which can be used to define a glass-transition tem¬ perature Tg.
The large difference in the volume coef¬ ficients of expansion between the prosthesis and bone- cement during surgery can be explained by the arguments of free volume, which is defined as the difference between the total volume of the material and the actual volume occupied by the molecules. As the temperature is lowered, the prosthesis, being a hard solid with negli- gable viscous behavior, can contract only by way of decreasing the amplitudes of vibration of the molecules about their equilibrium positions. In the course of curing cement in the rubbery state, however, there are packets of free volume, or holes too large to be lost by the mere decrease in vibration amplitudes of the molecules. If these holes are to be modified so as to conform to the equilibrium state of the material when the temperature is lowered, molecules or molecular segments must move over fairly long distances in order to accomplish this. When the jump frequency is high, as is the case for the curing cement, this rearrangement will be almost instantaneous, and the material will assume its new equilibrium volume soon after the tem¬ perature is changed. Consequently, the contraction of the cement is more significant than that of the prosthesis.
Occasionally, in current practice, a prosthe¬ sis is changed by simply removing the old prosthesis and putting a new one in its place, that is of the same size. This practice is attractive because removal of cement is difficult and often dangerous. Therefore, it would seem advantageous to re-insert a prosthesis in the intact cement bed. However, study by the present inven¬ tors shows that the quality of the bond between prosthe¬ sis and the already cured cement is not optimal and that partial re-cementing at least is preferable.
It has been possible to measure the strength of the mechanical coupling of an implant such as a hip prosthesis to the bone by mechanically exciting the com¬ posite bone-cement implant system and measuring the fre- quencies of the mechanical resonances. This method, known as the sonic probe technique, disclosed in an application for Letters Patent S.N. 026,462, filed April 2, 1979 (Babyn et al), shows that a strong mechanical coupling between the implant and the bone harboring the i plant results in a significant displacement of the resonant frequencies of the implant and of the bone from their pre-cemented or pre-bonded condition. The present inventors have made the important observation that the mechanical resonance frequencies of a recemented com¬ posite implant system remain virtually the same as that of the previously cemented system. This indicates that the coupling between the old and new cement masses by means of chemical bonding is very strong. Furthermore, a discontinuity of physical properties across the old cement/new interface may not be present, which is likely as polymethyl methacrylate is an amorphous polymer. Accordingly, it is highly advantageous to employ chem¬ ical bonding between components during surgery rather than the traditional mechanical keying at the bone/cement and prosthesis/cement interface. This can be accomplished by pre-coating the femur and/or the prosthesis with bone-cement before the actual operation and then uniting the two components by in-situ poly- merization of additional fresh bone cement during surgery. Pre-coated components ensure maximum mechani¬ cal coupling at the implant/cement interface which can be prepared controllably and reproducibly pre- operatively, thus shifting the emphasis at the time of surgery to the cement/cement and cement/bone interfaces. Since the quality of chemical bonding is less suscep- table to external disturbance than mechanical bonding during in-situ cement polymerization the incidence of loosening due to movements during surgery would drasti- cally be reduced. Furthermore, appropriate engineering and processing procedures can be employed to produce a layer of pre-bonded cement with the desired mechanical properties and devoid of bubbles and other defects pre- operatively on the surface of the femoral component. Another factor that can be controlled in a pre-coating implant is the modulus of elasticity of the cement pre- coating. The metal implant will have a Young's modulus typically 10 times higher than the cement that grips the implant. Thus at the implant-cement interface there is a discontinuity in stiffness. The greater this discon- tinuity, the greater will be the displacement of one surface relative to the other at the interface when the composite system is subjected to a mechanical load. By curing the cement in the implant coating under special conditions of temperature, pressure or by altering the composition of the cement pre-coating, it would be possible to produce a coating with elastic modulus intermediate between the metal of the implant and the cement as installed by the surgeon. This would produce a less abrupt discontinuity in elastic modulus from the implant into the bulk of the cement and would decrease the relative motion between the implant and the cement in which it is embedded. An even better tapering of elastic modulus from the implant into the cement could be achieved by loading the cement used in the pre- coating with a filler such as graphite fibers or glass fibers. Such gradual tapering of the elastic properties from the implant into the cement and in fact to the surrounding bone would produce a system which would have a minimum relative motion between different surfaces. This control of the relative motion would minimize the loosening due to mechanical loads. Corrugated surfaces on pre-coated cement layers would allow superior cement/cement bonding as well as quicker rate of heat dissipation during polymerization, which would imply faster rate and more complete polymerization.
Furthermore, effects of the methyl methacrylate monomer vapor and heat liberated during polymerization in surgery will be greatly reduced as the femur is pro¬ tected by a cement layer initially. Also, varus posi- tioning of the prosthesis will be minimized as now the prosthesis has at least some bone-cement surrounding it. Accordingly, it is a principal object of the present invention to provide an implant that shall over¬ come the above mentioned problems.
These and still further objects are addressed hereinafter.
The foregoing objects are achieved, generally, in a pre-coated body implant that includes, in com¬ bination, a structural member having a portion that is adapted to bond mechanically to a skeletal member of the body; and a cement pre-coating covering at least a substantial part of said portion of the structural member, which cement pre-coating clings to said portion. When the implant is installed in a patient a similar cement may be used in the bond cavity.
Fig. 1 is a isometric view of a pre-coated body implant;
Fig. 2 is a section view, slightly enlarged, taken upon the line 2 - 2 in Fig. 1 and looking in the direction of the arrows;
Fig. 3 is a view like that in Fig. 2 but of a modification of the implant of Fig. 2.
Fig. 4 is a graph showing the Young's modulus of methyl ethacrylate, (a material that may be used as the pre-coating on the implant in Fig. 1) as a function of absolute temperature, and
Fig. 5 is a graph showing specific volume as a function of absolute temperature for that same material.
Turning now to Fig. 1, the implant labeled 101 therein will be recognized as a prosthesis used in hip implant applications. A prosthesis of the type shown most generally is formed of metals such as stainless steel, cobalt-chromium, alloys e.g., (Vitallium) with only slight irregularities to aid cement fixation. The implant 101 has a stem 1, a shoulder 3, and a ball 4. As is known, the stem 1, when implanted in a body, is received by a cavity formed by a physician in the femur of a patient. The cavity is reamed to a size sufficient to receive the stem 1 and a volume of a doughy cement (e.g., methyl methacrylate, referred to as "MMA").
Ideally, the bone cavity should be free of blood and be dry so that no blood or other fluid interferes with grouting achieved by the cement to the bone or prosthe¬ sis. The inserted prosthesis is held in place by the operating physician until polymerization of the MMA is complete; no motion of the prosthesis should take place during the period of approximately ten to fifteen minutes it takes for polymerization to occur. (See said application for Letters Patent S.N. 026,462, Babyn et al, filed April 2, 1979 for a further discussion.)
In the usual installation, the implant 101, originally has a stem 1 which is shiny metal (usually Vitallium) and which fills that portion of the bone cavity not taken up by a cement. The implant 101 when installed in a femur is held there mostly by frictional interaction between the MMA and the femur at one bonding region and between the MMA and the implant at the other bonding region. The ideas herein are intended to strengthen the cement-to-implant bond which is a region that can loosen and fail, as previously noted herein.
In current practice, after the femoral canal is prepared, cement in the doughy stage is introduced. Despite the best attempts to keep the canal dry during this phase there is inevitably some admixture of blood and fat with the cement. After the maximum amount of cement has been introduced into the canal, the metal prosthesis is inserted into the cement. Ideally, the position of the prosthesis is not changed either during or after insertion so that no ridges or voids are formed at the metal-cement interface. Current practice is to introduce the cement and prosthesis as early in the polymerization process as possible to avoid ridges or voids caused by motion of the prosthesis in a more doughy or viscous cement. Post operative X-ray measure¬ ments show that a thickness of cement varying from essentially 0 to 1 centimeters can be achieved.
Data derived by the sonic probe technique disclosed in said application S.N. 026,462, suggest that currently employed clinical methods of assessing the completion of polymerization of bone cement is erroneous; i.e., an implant may be moved prior to complete cement polymerization causing micromotion of the completed prosthesis in its cement bed and perhaps inducing future loosening. While current techniques have been improved so that a better cement-bone inter¬ face is being achieved, it is still likely that a sub- optinal bond of prosthesis to cement is achieved, usually because of inadvertant motion of the prosthesis while the cement is polymerizing.
In accordance with the present teaching, a pre-coating 2 in Figs. 1 and 2 of MMA or some other acrylic or other material is applied to the stem 1 of the prosthesis. Experience indicates a layer 2 of about 3-5 millimeters in thickness (but not necessarily uniform) to be adequate for present purposes since a study of patients that have loose prosthesis shows that a prosthesis stem which occupies fifty percent of the femoral canal has less chance of loosening than a thinner stem. Also, as above indicated, the bond between the stem 1 and the pre-coating 2 is a mechanical bond which is achieved to a great degree by shrinkage of the pre-coating 2 upon curing; hence the pre-coating 2 must be thick enough to provide adequate tensile strength to assure that mechanical bond.
A number of salutary consequences flow from the use of a pre-coating implant in accordance with the present invention, as now discussed. A pre-coating in a metal prosthesis of optimum thickness ensures that there will be no prosthesis-bone contact in the event of improper prosthesis positioning, that is, the prosthesis will enjoy at least some cement covering and of optimal thickness. A pre-coating can be provided with irregu- larities (see the ridges on other irregularities marked 5 in the pre-coating labeled 2A in Fig. 3), thus increasing the contact area of cement/cement in the implant to provide a better mechanical and/or chemical bond. Irregularities cannot be provided in the metal stem 1 because they would result in concentrated stress which could lead to failure of that stem. The thickness of the pre-coating of layer 2 can be optimized, thereby reducing the amount of polymerized (doughy) cement introduced into the bone during implantation and, there- fore, the circulation would be less. It is felt on the basis of other reports that decreased exposure to monomer is desirable. Also, by increasing the mass of the prosthesis with a polymerized cement layer, better compaction of the doughy cement into the intesticies of cancellous bone can be achieved; i.e., a larger stem acts as a plunger forcing doughy cement under high pressure into cancellous bone. By pre-polymerization in a quality controlled setting a better bond can be achieved; e.g., a varying of the temperature of poly- merization and cooling can be employed to effect better bonding of cement-to-metal if greater contraction of cement can be achieved (see Figs. 4 and 5). The pre- coating can be applied in such a way that the elastic modulus of the coating takes on a value or range of values intermediate between the implant and the cement inserted during actual surgery. This gradation in ' stiffness will decrease the relative motion due to mechanical loading. Also, such problems as blood clots or fluid forming on the interface between cement and prosthesis is obviated.
Further modifications of the invention herein disclosed (e.g., successive layers of pre-coating material) will occur to persons skilled in the art and all such modifications are deemed to be within the spirit and scope of the invention as defined by the appended claims.

Claims

CLAIMS -14-
1. A pre-coated body implant that comprises, in combination: a structural member having a portion which is adapted to bond mechanically to a skeletal member of the body; and a cement pre-coating covering at least a substantial part of said portion of the struc¬ tural member, which cement pre-coating clings to said portion.
2. A pre-coated body implant as claimed in claim 1 in which the member is a hip prosthesis and in which said portion is the stem of the said prosthesis.
3. A pre-coated body implant as claimed in claim 1 in which the cement pre-coating is a thin layer of methyl methacrylate.
4. A pre-coated implant as claimed in claim 1 in which the cement pre-coating is shaped at the outer surface thereof in order to enchance bonding and posi¬ tioning of the implant.
5. A pre-coated implant as claimed in claim 1 in which the cement in the pre-coating has an elastic modulus intermediate between that of the implant and that of a body of cured cement said cured cement being inserted in unhardened form at the time of insertion of the implant into the body.
6. A method of implanting a prosthesis into a skeletal member of a human, that comprises: preparing a cavity in the skeletal member to receive the prosthesis which comprises a stem that is introduced into said cavity, covering the surface of the cavity with a cement coating, applying a cement pre-coating to said stem prior to insertion into said cavity, permitting the cement both in the cavity and on the stem to cure.
- Ό R
_p-V applying a further quantity of the cement in a doughy condition into the cavity and, while the cement is doughy, introducing the stem into the cavity.
PCT/US1980/001141 1979-09-10 1980-09-08 Pre-coated body implant WO1981000670A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19803049857 DE3049857A1 (en) 1979-09-10 1980-09-08 PRE-COATED BODY IMPLANT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73834 1979-09-10
US06/073,834 US4283799A (en) 1979-09-10 1979-09-10 Pre-coated body implant

Publications (1)

Publication Number Publication Date
WO1981000670A1 true WO1981000670A1 (en) 1981-03-19

Family

ID=22116082

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1980/001141 WO1981000670A1 (en) 1979-09-10 1980-09-08 Pre-coated body implant

Country Status (3)

Country Link
US (1) US4283799A (en)
GB (1) GB2072515B (en)
WO (1) WO1981000670A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258406A1 (en) * 1986-02-19 1988-03-09 Harrington Arthritis Res Beam construction and method.
EP0457464A1 (en) * 1990-05-17 1991-11-21 Howmedica International Inc. Prosthetic intramedullary femoral prosthesis with preformed sheath
EP0547155A1 (en) * 1990-09-04 1993-06-23 MIKHAIL, W.E.Michael Femoral stem prosthesis with preapplied cement mantle
US5443523A (en) * 1994-03-18 1995-08-22 Mikhail; W. E. Michael Femoral stem cement mantle

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491987A (en) * 1979-09-24 1985-01-08 Clemson University Method of orthopedic implantation and implant product
US4399814A (en) * 1981-04-27 1983-08-23 Massachusetts Institute Of Technology Method and apparatus for pressure-coated bones
US4919665A (en) * 1982-04-19 1990-04-24 Homsy Charles A Implantation of articulating joint prosthesis
US5222985B1 (en) * 1982-04-19 2000-10-24 Tranguil Prospects Ltd Implantation of articulating joint prosthesis
DE3334058C2 (en) * 1983-09-21 1985-07-25 Ulrich Dr.-Ing. 5600 Wuppertal Witzel Thigh section for a hip joint prosthesis
NL8304339A (en) * 1983-12-16 1985-07-16 Jonas Lindwer WEIGHT PROSTHESIS AND A TOOL TO BE USED THEREOF.
US4554686A (en) * 1984-02-29 1985-11-26 Technical Research Associates, Inc. Polymethylmethacrylate bone cements and methods for preparing such bone cements
US4735625A (en) * 1985-09-11 1988-04-05 Richards Medical Company Bone cement reinforcement and method
US4650489A (en) * 1986-01-30 1987-03-17 Massachusetts Institute Of Technology Prosthetic device for implantation in bone
US4795472A (en) * 1987-01-28 1989-01-03 Zimmer, Inc. Prosthesis with enhanced surface finish
WO1989010730A1 (en) * 1988-05-11 1989-11-16 Dall Desmond Meiring Hip joint femoral prosthesis
US5037437B1 (en) * 1990-01-18 1998-04-14 Univ Washington Method of bone preparation for prosthetic fixation
CA2156740A1 (en) * 1993-03-12 1994-09-15 Robert Poss Bone prosthesis and method of implanting the same
US5507832B1 (en) * 1993-10-26 1999-07-27 Howmedica Prosthesis with integral proximal spacer
US5645600A (en) * 1994-09-12 1997-07-08 Bimman; Lev A. High performance stem for arthroplasty
US5562734A (en) * 1995-05-31 1996-10-08 Zimmer, Inc. Method for reducing gamma radiation sterilization induced discoloration
US5658338A (en) * 1995-09-29 1997-08-19 Tullos; Hugh S. Prosthetic modular bone fixation mantle and implant system
DE19619166C2 (en) * 1996-05-11 1999-06-02 Heraeus Kulzer Gmbh Semi-finished product for the precise manufacture of an implantable prosthesis
KR100331026B1 (en) * 1999-06-09 2002-04-06 윤덕용 Artificial joint
US20050154463A1 (en) * 2000-08-30 2005-07-14 Trieu Hal H. Spinal nucleus replacement implants and methods
US20020026244A1 (en) * 2000-08-30 2002-02-28 Trieu Hai H. Intervertebral disc nucleus implants and methods
US7204851B2 (en) * 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US6620196B1 (en) 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US7503936B2 (en) * 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
EP1563808B1 (en) 2000-08-30 2008-04-02 Warsaw Orthopedic, Inc. Intervertebral disc nucleus implants
US7494509B1 (en) 2002-02-04 2009-02-24 Biomet Manufacturing Corp. Method and apparatus for providing a short-stemmed hip prosthesis
GB0207170D0 (en) * 2002-03-26 2002-05-08 Mcminn Derek J W Hip joint prosthesis
DE10227914A1 (en) * 2002-06-21 2004-01-15 Heraeus Kulzer Gmbh & Co. Kg Pharmaceutical preparation with delayed release of active ingredient, process for its preparation and use
US8389588B2 (en) * 2003-12-04 2013-03-05 Kensey Nash Corporation Bi-phasic compressed porous reinforcement materials suitable for implant
US20060058881A1 (en) * 2004-09-16 2006-03-16 Trieu Hai H Intervertebral disc nucleus implants and methods
US7303074B2 (en) * 2004-09-22 2007-12-04 Dombrowski Trudy M Foldable organizer device
US20060089719A1 (en) * 2004-10-21 2006-04-27 Trieu Hai H In situ formation of intervertebral disc implants
NL1032851C2 (en) * 2006-11-10 2008-05-14 Fondel Finance B V Kit and method for fixing a prosthesis or part thereof and / or filling bony defects.
US7842095B2 (en) * 2007-09-11 2010-11-30 Howmedica Osteonics Corp. Antibiotic bone cement spacer
US20100125303A1 (en) * 2008-11-20 2010-05-20 Daley Robert J Methods and apparatus for replacing biological joints using bone mineral substance in a suspended state
US20100125335A1 (en) * 2008-11-20 2010-05-20 Daley Robert J Methods and apparatus for replacing biological joints using bone cement in a suspended state
WO2011005197A1 (en) * 2009-07-10 2011-01-13 Milux Holding S.A. Hip joint device and method
WO2013040461A2 (en) * 2011-09-15 2013-03-21 Amedica Corporation Coated implants and related methods
FR2994077B1 (en) * 2012-08-06 2015-06-12 Univ Bordeaux 1 CONDYLIAN PROSTHESIS FOR TEMPOROMANDIBULAR JOINT

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3713860A (en) * 1970-08-31 1973-01-30 Atomic Energy Commission Bone substitute
US3790507A (en) * 1969-03-10 1974-02-05 Research Corp Plastic bone composition
US4051598A (en) * 1974-04-23 1977-10-04 Meer Sneer Dental implants
US4131597A (en) * 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US4202055A (en) * 1976-05-12 1980-05-13 Battelle-Institut E.V. Anchorage for highly stressed endoprostheses

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790507A (en) * 1969-03-10 1974-02-05 Research Corp Plastic bone composition
US3713860A (en) * 1970-08-31 1973-01-30 Atomic Energy Commission Bone substitute
US4051598A (en) * 1974-04-23 1977-10-04 Meer Sneer Dental implants
US4131597A (en) * 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US4202055A (en) * 1976-05-12 1980-05-13 Battelle-Institut E.V. Anchorage for highly stressed endoprostheses

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258406A1 (en) * 1986-02-19 1988-03-09 Harrington Arthritis Res Beam construction and method.
EP0258406A4 (en) * 1986-02-19 1989-10-12 Harrington Arthritis Res Ct Beam construction and method.
EP0457464A1 (en) * 1990-05-17 1991-11-21 Howmedica International Inc. Prosthetic intramedullary femoral prosthesis with preformed sheath
US5197990A (en) * 1990-05-17 1993-03-30 Howmedica International, Inc. Prosthetic intramedullary femoral prosthesis with preformed sheath
EP0547155A1 (en) * 1990-09-04 1993-06-23 MIKHAIL, W.E.Michael Femoral stem prosthesis with preapplied cement mantle
EP0547155A4 (en) * 1990-09-04 1993-09-15 Mikhail, W.E.Michael Femoral stem prosthesis with preapplied cement mantle
US5443523A (en) * 1994-03-18 1995-08-22 Mikhail; W. E. Michael Femoral stem cement mantle

Also Published As

Publication number Publication date
US4283799A (en) 1981-08-18
GB2072515B (en) 1983-08-24
GB2072515A (en) 1981-10-07

Similar Documents

Publication Publication Date Title
US4283799A (en) Pre-coated body implant
US4881536A (en) Method and apparatus for prosthesis placement
Huiskes et al. Local stresses and bone adaption around orthopedic implants
US5984968A (en) Reinforcement for an orthopedic implant
US5343877A (en) Orthopedic implant and method
US7427296B2 (en) Total knee joint mold and methods
CA1195805A (en) Method of orthopedic implantation and implant product
US6602293B1 (en) Polymeric composite orthopedic implant
EP0315283B1 (en) A method of shaping an endoprosthesis
US11458021B2 (en) Anisotropic materials in medical devices
US7947135B2 (en) Proximally self-locking long bone prosthesis
AU573721B2 (en) Polymeric acrylic prosthesis
US5222985A (en) Implantation of articulating joint prosthesis
US6217620B1 (en) Reinforcing an orthopedic implant
US4851004A (en) Implantation of articulating joint prosthesis
Breusch et al. The mechanical properties of PMMA bone cement
US4919665A (en) Implantation of articulating joint prosthesis
Huiskes Biomechanics of bone—implant interactions
US4636214A (en) Implantation of articulating joint prosthesis
GB2118441A (en) Articulating joint prostheses
Walker et al. Design and application of combined hip-knee intramedullary joint replacements
Mackerle A finite element bibliography for biomechanics (1987-1997)
US11344419B1 (en) Total knee joint mold and methods for gap balancing and joint line restoration
Morton et al. Cemented Stems in Total Hip Arthroplasty: What is Old and What is New Again?
Huettner et al. Carbon based materials in medical applications

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): CH DE GB

RET De translation (de og part 6b)

Ref document number: 3049857

Country of ref document: DE

Date of ref document: 19820304

WWE Wipo information: entry into national phase

Ref document number: 3049857

Country of ref document: DE